formoterol

Trials studying formoterol

• phase3Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthmarecruitingn=416
• phase4Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilatorsrecruitingn=72
• phase3Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)completedn=708
• phase3A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroidcompletedn=1,377
• phase2Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthmarecruitingn=1,147
• phase2A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Diseasenot yet recruitingn=90
• phase3Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)completedn=1,714
• —Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]active not recruitingn=152